头痛诊断与自杀未遂及自杀死亡风险
这项基于丹麦全国人群的队列研究纳入119486例头痛患者并按5:1匹配597430名无头痛对照,发现头痛患者15年自杀未遂绝对风险0.78% vs 对照0.33%,自杀死亡0.21% vs 0.15%;自杀未遂HR 2.04、自杀死亡HR 1.40,各头痛类型结果一致,三叉自主神经性头痛和创伤后头痛关联更强。
要点
- 头痛患者15年自杀未遂绝对风险0.78% vs 对照0.33%(风险差0.45%)。
- 头痛患者自杀未遂HR 2.04(95%CI 1.84-2.27),自杀死亡HR 1.40(95%CI 1.17-1.68)。
- 三叉自主神经性头痛和创伤后头痛与自杀风险的关联更强。
核心结论
- 头痛诊断与自杀未遂及自杀死亡存在稳健且持续的关联,作者认为行为健康评估和治疗对这些患者可能重要。
研究设计与样本
- 基于丹麦1995至2020年人群的队列研究,纳入15岁及以上首次诊断头痛者119486例(女性83046例,69.5%),按性别和出生年以5:1匹配无头痛诊断对照597430例(女性415230例,69.5%)。
- 参与者中位年龄40.1岁(IQR 29.1-51.6),数据分析于2023年5月至2024年5月进行。
主要发现
- 头痛组15年自杀未遂绝对风险0.78%(95%CI 0.72%-0.85%)vs 对照组0.33%(95%CI 0.31%-0.35%),风险差0.45%(95%CI 0.39%-0.53%)。
- 头痛组15年自杀死亡绝对风险0.21%(95%CI 0.17%-0.24%)vs 对照组0.15%(95%CI 0.13%-0.16%),风险差0.06%(95%CI 0.02%-0.10%)。
- 头痛组自杀未遂风险HR 2.04(95%CI 1.84-2.27),自杀死亡风险HR 1.40(95%CI 1.17-1.68),均高于对照组。
- 结果在各头痛类型中一致,三叉自主神经性头痛和创伤后头痛的关联更强。
关键数值与推荐
- 偏头痛、紧张型头痛、创伤后头痛及三叉自主神经性头痛的诊断依据ICD-10编码,来源于住院、急诊及门诊专科就诊记录。
- 自杀未遂依据丹麦国家患者登记和丹麦精神科中央研究登记中的ICD-10编码识别,自杀死亡依据丹麦死因登记识别。
临床怎么用
- 作者认为,行为健康评估和治疗对这些头痛患者可能重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although past research suggests an association between migraine and attempted suicide, there is limited research regarding risk of attempted and completed suicide across headache disorders. OBJECTIVE: To examine the risk of attempted and completed suicide associated with diagnosis of migraine, tension-type headache, posttraumatic headache, and trigeminal autonomic cephalalgia (TAC). DESIGN, SETTING, AND PARTICIPANTS: This was a population-based cohort study of Danish citizens from 1995 to 2020. The setting was in Denmark, with a population of 5.6 million people. Persons 15 years and older who were diagnosed with headache were matched by sex and birth year to persons without headache diagnosis with a ratio of 5:1. Data analysis was conducted from May 2023 to May 2024. EXPOSURES: First-time headache diagnoses identified from inpatient hospitalizations, emergency department visits, and outpatient specialty clinic visits using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes. MAIN OUTCOMES AND MEASURES: Diagnostic codes from the ICD-10 were used to identify attempted suicide from the Danish National Patient Registry and the Danish Psychiatric Central Research Register and completed suicides from the Danish Register of Causes of Death. Absolute risks (ARs) and risk differences (RDs) for attempted and completed suicide were calculated using the cumulative incidence function. Hazard ratios (HRs) for attempted and completed suicide associated with headache diagnosis were computed adjusting for age, sex, year, education, income, baseline comorbidities, and accounting for competing risk of death. RESULTS: In total, 119 486 persons (83 046 female [69.5%]) diagnosed with headache were identified and matched with 597 430 persons (415 230 female [69.5%]) drawn from the general population. Participants' median (IQR) age was 40.1 (29.1-51.6) years. The 15-year AR of attempted suicide among persons diagnosed with headache was 0.78% (95% CI, 0.72%-0.85%) vs 0.33% (95% CI, 0.31%-0.35%) in the comparison cohort (RD, 0.45%; 95% CI, 0.39%-0.53%). The 15-year AR of completed suicide among persons diagnosed with headache was 0.21% (95% CI, 0.17%-0.24%) vs 0.15% (95% CI, 0.13%-0.16%) in the comparison cohort (RD, 0.06%; 95% CI, 0.02%-0.10%). The hazards of attempted suicide (HR, 2.04; 95% CI, 1.84-2.27) and completed suicide (HR, 1.40; 95% CI, 1.17-1.68) were elevated among persons with headache vs comparison cohort members. Findings were consistent across headache types, with stronger associations for TACs and posttraumatic headache. CONCLUSIONS AND RELEVANCE: Results of this cohort study revealing the robust and persistent association of headache diagnoses with attempted and completed suicide suggest that behavioral health evaluation and treatment may be important for these patients.
引用
- Elser H, Farkas DK, Fuglsang CH, et al. Risk of Attempted and Completed Suicide in Persons Diagnosed With Headache. JAMA Neurol. 2025. PMID: 39899309. doi:10.1001/jamaneurol.2024.4974
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。